Molecular Regulation of Stem Cell Quiescence
干细胞静止的分子调控
基本信息
- 批准号:10685860
- 负责人:
- 金额:$ 48.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Stem cells are responsible for homeostasis and repair of most of the tissues in the body. Many populations
of stem cells persist in a quiescent state until stimulated to enter the cell cycle, proliferate, and differentiate into
functional cells of the particular tissue. In recent years, work from our group and others has drawn attention to
several unexpected characteristics of quiescent muscle stem cells (MuSCs), many of which are shared by
other quiescent stem cell populations. These include the active maintenance of cellular quiescence, unique
metabolic and energetic mechanism in quiescent and activating stem cells, and the presence of large numbers
of transcripts for which no protein product is detected. This latter observation raises three major questions that
are the focus of this proposal: 1) Is the transcriptional profile of MuSCs (or any other stem cell population) in
vivo similar to that of cells that have been isolated and purified by fluorescence-activated cell sorting (FACS)?
2) What are the post-transcriptional mechanisms that are responsible for the absence of protein products when
transcripts are present in the quiescent cells? 3) What are consequences of accumulation of those protein
products in quiescent cells that necessitate mechanisms to prevent such an accumulation?
To address these issues, this proposal is divided into three Specific Aims as follows. Aim 1: To study the
dynamics of the quiescent and activating MuSC transcriptome. We will use methods to label nascent RNA in
vivo (using 4-thiouracil (TU) and 5-ethynyl uridine (EU)) followed by labelled transcript purification and RNA-
seq to assess MuSC transcript dynamics in vivo and ex vivo. We will also profile transcripts using RNA-seq of
fixed MuSCs to assess transcript abundance in vivo. Aim 2: To study the translatome and proteome of MuSCs
in vivo and ex vivo. We will isolate ribosome-associated transcripts (using the RiboTag mouse) followed by
RNA-seq and OP-puromycin labelling of labelled proteins followed by mass spectrometry to assess transcripts
that are associated with the polyribosome and translated into detectable proteins in quiescent MuSCs in vivo
and ex vivo. We will also assess protein translation in MuSCs in vivo and ex vivo during the process of MuSC
activation. Aim 3: To understand the regulation of MyoD translation and the consequences of aberrant MyoD
protein expression in quiescent MuSCs. Based on Preliminary Data, we will test the hypothesis that Staufen1
suppresses the translation of the MyoD transcript in quiescent cells, and we will analyze the functional
consequences of MyoD expression in quiescent MuSCs by inhibiting those suppressive mechanisms
genetically and using an siRNA approach. The overall goals of these studies are to provide a more accurate
assessment of the in vivo state of the quiescent stem cell and to understand in greater detail the molecular
mechanisms that maintain stem cell quiescence and at the same time prime the cell for activation and
differentiation.
项目概要
干细胞负责体内大多数组织的稳态和修复。许多人口
的干细胞持续处于静止状态,直到受到刺激进入细胞周期、增殖并分化为
特定组织的功能细胞。近年来,我们小组和其他人的工作引起了人们的关注
静止肌肉干细胞(MuSC)的一些意想不到的特征,其中许多是
其他静止干细胞群。这些包括积极维持细胞静止、独特的
静止和激活干细胞的代谢和能量机制,以及大量存在
未检测到蛋白质产物的转录本。后一个观察提出了三个主要问题:
该提案的重点是:1)MuSC(或任何其他干细胞群)的转录谱是否存在于
体内与通过荧光激活细胞分选(FACS)分离和纯化的细胞相似吗?
2) 转录后机制导致蛋白质产物缺失的原因是什么
转录本存在于静止细胞中吗? 3)这些蛋白质的积累会产生什么后果
静止细胞中的产物是否需要机制来防止这种积累?
为了解决这些问题,该提案分为以下三个具体目标。目标1:研究
静态和激活 MuSC 转录组的动态。我们将使用方法来标记新生RNA
体内(使用 4-硫尿嘧啶 (TU) 和 5-乙炔基尿苷 (EU)),然后进行标记转录物纯化和 RNA-
seq 评估 MuSC 体内和离体转录动态。我们还将使用 RNA-seq 分析转录本
固定 MuSC 以评估体内转录本丰度。目标 2:研究 MuSC 的翻译组和蛋白质组
体内和离体。我们将分离核糖体相关转录本(使用 RiboTag 小鼠),然后
对标记蛋白进行 RNA-seq 和 OP-嘌呤霉素标记,然后进行质谱分析以评估转录本
与多核糖体相关并在体内翻译成静态 MuSC 中可检测的蛋白质
和离体。我们还将在 MuSC 过程中体内和离体评估 MuSC 中的蛋白质翻译
激活。目标 3:了解 MyoD 翻译的调控以及异常 MyoD 的后果
静态 MuSC 中的蛋白质表达。根据初步数据,我们将检验以下假设:Staufen1
抑制静止细胞中 MyoD 转录本的翻译,我们将分析其功能
通过抑制这些抑制机制,静态 MuSC 中 MyoD 表达的后果
遗传并使用 siRNA 方法。这些研究的总体目标是提供更准确的
评估静止干细胞的体内状态并更详细地了解分子
维持干细胞静止并同时为细胞激活做好准备的机制
差异化。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tubastatin A maintains adult skeletal muscle stem cells in a quiescent state ex vivo and improves their engraftment ability in vivo.
图巴他汀 A 使成体骨骼肌干细胞在体外维持静止状态,并提高其在体内的植入能力。
- DOI:
- 发表时间:2022-01-11
- 期刊:
- 影响因子:5.9
- 作者:Arjona, Marina;Goshayeshi, Armon;Rodriguez;Brett, Jamie O;Both, Pieter;Ishak, Heather;Rando, Thomas A
- 通讯作者:Rando, Thomas A
Hairless regulates heterochromatin maintenance and muscle stem cell function as a histone demethylase antagonist.
Hairless 作为组蛋白去甲基酶拮抗剂调节异染色质维持和肌肉干细胞功能。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:11.1
- 作者:Liu, Ling;Rodriguez;Huang, Polly;Huang, Albin;Lieu, Alexander;Mao, Michelle;Chung, Mingyu;Yang, Sharon;Yu, Kevin;Charville, Gregory W;Gan, Qiang;Rando, Thomas A
- 通讯作者:Rando, Thomas A
Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity.
成体干细胞静止的调节及其在维持组织完整性中的功能。
- DOI:
- 发表时间:2023-05
- 期刊:
- 影响因子:0
- 作者:de Morree, Antoine;Rando, Thomas A
- 通讯作者:Rando, Thomas A
Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
I 型和 II 型受体在肌肉生长抑制素和激活素 A 调节骨骼肌生长中的功能冗余。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:11.1
- 作者:Lee, Se;Lehar, Adam;Liu, Yewei;Ly, Chi Hai;Pham, Quynh;Michaud, Michael;Rydzik, Renata;Youngstrom, Daniel W;Shen, Michael M;Kaartinen, Vesa;Germain;Rando, Thomas A
- 通讯作者:Rando, Thomas A
Dynamical modeling reveals RNA decay mediates the effect of matrix stiffness on aged muscle stem cell fate.
动力学模型揭示 RNA 衰减介导基质硬度对衰老肌肉干细胞命运的影响。
- DOI:
- 发表时间:2023-03-02
- 期刊:
- 影响因子:0
- 作者:Hettinger, Zachary R;Hu, Sophia;Mamiya, Hikaru;Sahu, Amrita;Iijima, Hirotaka;Wang, Kai;Gilmer, Gabrielle;Miller, Amanda;Nasello, Gabriele;Dâ Amore, Antonio;Vorp, David A;Rando, Thomas A;Xing, Jianhua;Ambrosio, Fabrisia
- 通讯作者:Ambrosio, Fabrisia
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS A. RANDO其他文献
THOMAS A. RANDO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS A. RANDO', 18)}}的其他基金
Genomic Instability as A Driver of Stem Cell Exhaustion
基因组不稳定性是干细胞衰竭的驱动因素
- 批准号:
10722284 - 财政年份:2023
- 资助金额:
$ 48.7万 - 项目类别:
Mechanisms of adipogenic and fibrotic degeneration of muscle
肌肉脂肪形成和纤维变性的机制
- 批准号:
10259577 - 财政年份:2021
- 资助金额:
$ 48.7万 - 项目类别:
ShEEP Request for ImageXpress Pico Automated Cell Imaging System
ShEEP 请求 ImageXpress Pico 自动细胞成像系统
- 批准号:
9906104 - 财政年份:2019
- 资助金额:
$ 48.7万 - 项目类别:
相似国自然基金
知识数据化背景下建筑节能规范规定性条款智能检查方法及其泛化性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
法律的软性约束力:基于公共品博弈中最低贡献规定的实验研究
- 批准号:72003101
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
科研人员对科学基金项目管理规定解读及展示的需求分析
- 批准号:
- 批准年份:2020
- 资助金额:20 万元
- 项目类别:专项基金项目
涉及例外函数的亚纯函数正规定则与Picard型定理的研究
- 批准号:
- 批准年份:2020
- 资助金额:32 万元
- 项目类别:地区科学基金项目
辅酶A类代谢中间产物参与组蛋白表观遗传修饰调控肝细胞代谢网络对高油脂营养应答的机制研究
- 批准号:91957110
- 批准年份:2019
- 资助金额:83.0 万元
- 项目类别:重大研究计划
相似海外基金
Developmental mechanisms specifying vagal innervation of organ targets
指定器官目标迷走神经支配的发育机制
- 批准号:
10752553 - 财政年份:2024
- 资助金额:
$ 48.7万 - 项目类别:
High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes
神经精神和神经发育障碍风险基因的高通量体内和体外功能和多组学筛选
- 批准号:
10643398 - 财政年份:2023
- 资助金额:
$ 48.7万 - 项目类别:
Stress response signaling as a metabolic sensor in reproduction
应激反应信号作为生殖中的代谢传感器
- 批准号:
10644353 - 财政年份:2023
- 资助金额:
$ 48.7万 - 项目类别:
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 48.7万 - 项目类别: